Literature DB >> 11519637

Risk taking by adolescents with maladaptive behavior histories.

S D Lane1, D R Cherek.   

Abstract

"High-risk" adolescents with maladaptive behavior histories and control adolescents (15-17 years of age) participated in a laboratory experiment that measured aspects of risk-taking behavior. High-risk adolescents had behavioral profiles entailing combinations of past substance use disorder, early onset substance use, conduct disorder, criminal history, and dropping out of school. A risk-taking task presented participants with "risky" and nonrisky response options. The risky response option offered a low probability of a large monetary reward or a high probability of a smaller monetary loss and resulted in a net loss of monetary earnings. The nonrisky option protected current earnings. High-risk adolescents chose the risky option more often, had lower overall earnings, and were more likely to persist in making (losing) risky responses following a single gain on the risky option. The data replicate previous findings with high-risk adults.

Entities:  

Mesh:

Year:  2001        PMID: 11519637     DOI: 10.1037/1064-1297.9.1.74

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  10 in total

1.  Psychosocial problems and recruitment of incentive neurocircuitry: exploring individual differences in healthy adolescents.

Authors:  James M Bjork; Ashley R Smith; Gang Chen; Daniel W Hommer
Journal:  Dev Cogn Neurosci       Date:  2011-10       Impact factor: 6.464

2.  Cumulative gains enhance striatal response to reward opportunities in alcohol-dependent patients.

Authors:  Jodi M Gilman; Ashley R Smith; James M Bjork; Vijay A Ramchandani; Reza Momenan; Daniel W Hommer
Journal:  Addict Biol       Date:  2014-04-23       Impact factor: 4.280

Review 3.  Dopamine ups and downs in vulnerability to addictions: a neurodevelopmental model.

Authors:  Marco Leyton; Paul Vezina
Journal:  Trends Pharmacol Sci       Date:  2014-04-30       Impact factor: 14.819

4.  Incentive-elicited mesolimbic activation and externalizing symptomatology in adolescents.

Authors:  James M Bjork; Gang Chen; Ashley R Smith; Daniel W Hommer
Journal:  J Child Psychol Psychiatry       Date:  2009-12-11       Impact factor: 8.982

5.  Initial nicotine sensitivity in humans as a function of impulsivity.

Authors:  Kenneth A Perkins; Caryn Lerman; Sarah B Coddington; Christopher Jetton; Joshua L Karelitz; John A Scott; Annette S Wilson
Journal:  Psychopharmacology (Berl)       Date:  2008-07-05       Impact factor: 4.530

6.  Altered cingulate and insular cortex activation during risk-taking in methamphetamine dependence: losses lose impact.

Authors:  Joshua L Gowin; Jennifer L Stewart; April C May; Tali M Ball; Marc Wittmann; Susan F Tapert; Martin P Paulus
Journal:  Addiction       Date:  2013-10-24       Impact factor: 6.526

7.  Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings.

Authors:  Gabriel S Dichter; Cara A Damiano; John A Allen
Journal:  J Neurodev Disord       Date:  2012-07-06       Impact factor: 4.025

8.  Alcohol effects on human risk taking.

Authors:  Scott D Lane; Don R Cherek; Cynthia J Pietras; Oleg V Tcheremissine
Journal:  Psychopharmacology (Berl)       Date:  2003-11-25       Impact factor: 4.530

9.  Risky decisions and their consequences: neural processing by boys with Antisocial Substance Disorder.

Authors:  Thomas J Crowley; Manish S Dalwani; Susan K Mikulich-Gilbertson; Yiping P Du; Carl W Lejuez; Kristen M Raymond; Marie T Banich
Journal:  PLoS One       Date:  2010-09-22       Impact factor: 3.240

10.  Adolescents' Neural Processing of Risky Decisions: Effects of Sex and Behavioral Disinhibition.

Authors:  Thomas J Crowley; Manish S Dalwani; Susan K Mikulich-Gilbertson; Susan E Young; Joseph T Sakai; Kristen M Raymond; Shannon K McWilliams; Melissa J Roark; Marie T Banich
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.